CHUNHONG HE,COLIN ZHANG,DING-QUAN QIAN,JINCONG ZHUO,LIANG LU,LIANGXING WU,MEIZHONG XU,WENQING YAO,YAPING SUN
申请号：
BR112014030812
公开号：
BR112014030812A2
申请日:
2013.06.12
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract the present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, which are inhibitors of one or more fgfr enzymes and are useful in the treatment of fgfr-associated diseases such as cancer. ************************ Translation of abstract summary "Tricyclic compounds substituted as fgfr inhibitors". The present invention relates to tricyclic compounds of formula I and pharmaceutical compositions thereof which are inhibitors of one or more Fgfr enzymes and are useful in the treatment of Gffr-associated diseases, such as cancer. 23297969v1 1/1 23297969v1abstract the present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more fgfr enzymes and are useful in the treatment of fgfr-associated diseases such as cancer. ************************ tradução do resumo resumo "compostos tricíclicos substituídos como inibidores de fgfr". a presente invenção se refere a compostos tricíclicos de fórmula i e composições farmacêuticas do mesmo que são inibidores de uma ou mais enzimas fgfr e são úteis no tratamento de doenças associadas a fgfr, tal como câncer. 23297969v1 1/1 23297969v1
